TABLE 1.
GeneID TSKa | Gene annotation | Immunoprecipitation assaysb | Fold change in transfectantsc | Fold change in metacyclicsd |
---|---|---|---|---|
Tc00.1047053508039.70 | Hypothetical protein | +,+,- | -4.9 | 0.34 ± 0.02 |
Tc00.1047053506753.110 | Hypothetical protein (cytochrome b5-like) | -,-,- | -3.5 | NDe |
Tc00.1047053504013.110 | Serine/threonine-protein phosphatase 2A | +,+,+ | -3.6 | 8.67 ± 1.02 |
Tc00.1047053511523.20 | Hypothetical protein | +,+,- | -3.6 | 6.57 ± 0.53 |
Tc00.1047053507641.80 | XRND1 exonuclease | +,+,- | -4.0 | 4.23 ± 0.35 |
Tc00.1047053509179.50 | Hypothetical protein | +,+,- | -3.4 | 70.3 ± 6.48 |
AAS47054 | PAT6 amino acid transporter | +,+,+ | -3.0 | 1.54 ± 0.14 |
Tc00.1047053511215.119 | 69 kDa paraflagellar rod protein putative | +,+,+ | -8.4 | 7.81 ± 0.68 |
EH035829 | Hypothetical protein | ND | -4.7 | ND |
Gene code from Trypanosoma cruzi Sequencing Consortium (when this is not available, the GenBank™ sequence ID is provided instead).
Presence (+) or absence (-) of the affinity purified transcripts in the three independent immunoprecipitation assays.
Fold change value of decreased expression determined by microarray analysis.
Fold change value of transcript expression levels in metacyclic trypomastigotes compared with epimastigote forms by quantitative PCR assays.
ND, not determined.